Recent FDA Approvals in Leukemia and Lymphoma
Description
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively. Coverage of stories discussed this week on ascopost.com: FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma To listen to more podcasts from ASCO, visit asco.org/podcasts.
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively. Coverage of stories discussed this week on ascopost.com: FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma To listen to more podcasts from ASCO, visit asco.org/podcasts.
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively. Coverage of stories discussed this week on ascopost.com: FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma To listen to more podcasts from ASCO, visit asco.org/podcasts.
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively. Coverage of stories discussed this week on ascopost.com: FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma To listen to more podcasts from ASCO, visit asco.org/podcasts.
United States
